Global molecular diagnostics market expected to generate around USD 14.56 billion by 2025, at a CAGR of around 8.9% between 2019 and 2025. Molecular diagnostics includes the molecular biology techniques that are used for the detection of biomarkers present in genomes or proteomes.
The report covers a forecast and an analysis of the molecular diagnostics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the molecular diagnostics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the molecular diagnostics market on a global level.
In order to give the users of this report a comprehensive view of the molecular diagnostics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.
The study provides a decisive view of the molecular diagnostics market by segmenting it on the basis of product and services, application, technology, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.
Some major players of the global molecular diagnostics market are Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Novartis, Johnson and Johnson, bioMerieux, Bio-Rad Laboratories, Qiagen NV, Siemens Healthcare, Danaher Corporation, and Hologic.
This report segments the global molecular diagnostics market into:
Global Molecular Diagnostics Market: Product and Services Analysis
Global Molecular Diagnostics Market: Application Analysis
Global Molecular Diagnostics Market: Technology Analysis
Global Molecular Diagnostics Market: End-User Analysis
Global Molecular Diagnostics Market: Regional Analysis
List of Figures
1. Market research process
2. Market research methodology
3. Global molecular diagnostics market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Molecular Diagnostics market attractiveness analysis, by product and services
6. Molecular Diagnostics market attractiveness analysis, by application
7. Molecular Diagnostics market attractiveness analysis, by technology
8. Molecular Diagnostics market attractiveness analysis, by End-User
9. Molecular Diagnostics market: market attractiveness analysis, by region
10. Company market share analysis, 2018
11. Global molecular diagnostics market revenue share by product and services, 2018 and 2025
12. Global molecular diagnostics market for reagents and kits, 2016–2025 (USD Billion)
13. Global molecular diagnostics market for instruments, 2016–2025 (USD Billion)
14. Global molecular diagnostics market for software and services, 2016–2025 (USD Billion)
15. Global molecular diagnostics market revenue share by application, 2018 and 2025
16. Global molecular diagnostics market for genetic tests, 2016–2025 (USD Billion)
17. Global molecular diagnostics market for infectious disease, 2016–2025 (USD Billion)
18. Global molecular diagnostics market for oncology, 2016–2025 (USD Billion)
19. Global molecular diagnostics market for others, 2016–2025 (USD Billion)
20. Global molecular diagnostics market revenue share by technology, 2018 and 2025
21. Global molecular diagnostics market for PCR, 2016–2025 (USD Billion)
22. Global molecular diagnostics market for INAAT, 2016–2025 (USD Billion)
23. Global molecular diagnostics market for DNA sequencing and NGS, 2016–2025 (USD Billion)
24. Global molecular diagnostics market for in situ hybridization, 2016–2025 (USD Billion)
25. Global molecular diagnostics market for DNA microarrays, 2016–2025 (USD Billion)
26. Global molecular diagnostics market for others, 2016–2025 (USD Billion)
27. Global molecular diagnostics market revenue share by End-User, 2018 and 2025
28. Global molecular diagnostics market for diagnostic laboratories, 2016–2025 (USD Billion)
29. Global molecular diagnostics market for hospitals, 2016–2025 (USD Billion)
30. Global molecular diagnostics market for others, 2016–2025 (USD Billion)
31. North America molecular diagnostics market, 2016–2025 (USD Billion)
32. Europe molecular diagnostics market, 2016–2025 (USD Billion)
33. Asia Pacific molecular diagnostics market, 2016–2025 (USD Billion)
34. Latin America molecular diagnostics market, 2016–2025 (USD Billion)
35. The Middle East and Africa molecular diagnostics market, 2016–2025 (USD Billion)
List of Tables
1. Global molecular diagnostics market: Market Snapshot
2. Drivers of the global molecular diagnostics market: Impact analysis
3. Restraints of the global molecular diagnostics market: Impact analysis
4. North America molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
5. North America molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
6. North America molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
7. North America molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
8. The U.S. molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
9. The U.S. molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
10. The U.S. molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
11. The U.S. molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
12. Canada molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
13. Canada molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
14. Canada molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
15. Canada molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
16. Europe molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
17. Europe molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
18. Europe molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
19. Europe molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
20. UK molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
21. UK molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
22. UK molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
23. UK molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
24. Germany molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
25. Germany molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
26. Germany molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
27. Germany molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
28. France molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
29. France molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
30. France molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
31. France molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
32. Rest of Europe molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
33. Rest of Europe molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
34. Rest of Europe molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
35. Rest of Europe molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
36. Asia Pacific molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
37. Asia Pacific molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
38. Asia Pacific molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
39. Asia Pacific molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
40. China molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
41. China molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
42. China molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
43. China molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
44. Japan molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
45. Japan molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
46. Japan molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
47. Japan molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
48. India molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
49. India molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
50. India molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
51. India molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
52. Rest of Asia Pacific molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
53. Rest of Asia Pacific molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
54. Rest of Asia Pacific molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
55. Rest of Asia Pacific molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
56. Latin America molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
57. Latin America molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
58. Latin America molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
59. Latin America molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
60. Brazil molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
61. Brazil molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
62. Brazil molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
63. Brazil molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
64. Rest of Latin America molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
65. Rest of Latin America molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
66. Rest of Latin America molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
67. Rest of Latin America molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
68. The Middle East and Africa molecular diagnostics market revenue, by product and services, 2016–2025 (USD Billion)
69. The Middle East and Africa molecular diagnostics market revenue, by application, 2016–2025 (USD Billion)
70. The Middle East and Africa molecular diagnostics market revenue, by technology, 2016–2025 (USD Billion)
71. The Middle East and Africa molecular diagnostics market revenue, by End-User, 2016–2025 (USD Billion)
Molecular diagnostics includes the molecular biology techniques that are used for the detection of biomarkers present in genomes or proteomes. Molecular diagnostic consist of a family of techniques like PCR, DNA or gene microarray, INAAT, NGS, etc. Molecular diagnostics is the result of the fruitful interplay between genomics knowledge, laboratory medicine, and technology in the field of molecular genetics.
According to the WHO, cancer is the second leading mortality cause worldwide. The growing cancer prevalence worldwide is fueling the research activities for cancer treatment. As per the National Cancer Institute, in 2018, about 1,700,000 new cancer cases were diagnosed in the U.S. According to the Centers for Disease Control and Prevention, about 9,272 new cases of tuberculosis were registered in the U.S. in 2016. This growing incidence of infectious diseases and cancer is increasing the demand for molecular diagnostics techniques. The rapid advancements witnessed in the molecular biology technologies, development of molecular diagnostic technologies to automated processes, growing awareness about molecular diagnostics usage for the detection of different diseases in developing countries, and increasing government funding for research in molecular biology are driving the global molecular diagnostics market. However, the high cost of technologies and the lack of a skilled workforce to handle the instruments are hindering the global molecular diagnostics market growth.
The molecular diagnostics market is fragmented into product and services, application, technology, and end-user. Based on product and services, the molecular diagnostics market includes instruments, reagents and kits, and software and services. The application segment of the molecular diagnostics market includes genetic tests, infectious diseases (HIV, hepatitis, HPV, CT/NG, influenza, TB, and others), oncology (life breast cancer, lung cancer, colorectal cancer, prostate cancer, and other cancers), and others. The oncology segment is projected to show the highest growth rate in the molecular diagnostics market in the years ahead. Based on technology, the market is fragmented into DNA microarrays, DNA sequencing and NGS, polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, and others. The end-user segment comprises diagnostic laboratories, hospitals, and others.
By region, North America dominated the market in 2018, owing to the early introduction of highly developed equipment for research activities, the presence of highly skilled workforce, and an increase in the number of projects for the development of new molecular diagnostic technologies. The Asia Pacific molecular diagnostics market is anticipated to show the highest year-to-year growth in the upcoming years, due to the rising investments by government and leading companies for R&D, high prevalence of infectious diseases in the developing countries of China and India, and growing awareness about molecular diagnostics usage for different disease detection.
Some major players of the global molecular diagnostics market are Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Novartis, Johnson and Johnson, bioMerieux, Bio-Rad Laboratories, Qiagen NV, Siemens Healthcare, Danaher Corporation, and Hologic.
Request the coronavirus impact analysis across industries and markets
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed